Reeves, M.; Chambers, A.; Shrestha, A.; Duarte, S.; Zarrinpar, A.; Malany, S.; Peddibhotla, S.
Targeting CXCR6 Disrupts β-Catenin Signaling and Enhances Sorafenib Response in Hepatocellular Carcinoma. Cancers 2025, 17, 3818.
https://doi.org/10.3390/cancers17233818
AMA Style
Reeves M, Chambers A, Shrestha A, Duarte S, Zarrinpar A, Malany S, Peddibhotla S.
Targeting CXCR6 Disrupts β-Catenin Signaling and Enhances Sorafenib Response in Hepatocellular Carcinoma. Cancers. 2025; 17(23):3818.
https://doi.org/10.3390/cancers17233818
Chicago/Turabian Style
Reeves, Morgan, Anastasia Chambers, Abhishek Shrestha, Sergio Duarte, Ali Zarrinpar, Siobhan Malany, and Satyamaheshwar Peddibhotla.
2025. "Targeting CXCR6 Disrupts β-Catenin Signaling and Enhances Sorafenib Response in Hepatocellular Carcinoma" Cancers 17, no. 23: 3818.
https://doi.org/10.3390/cancers17233818
APA Style
Reeves, M., Chambers, A., Shrestha, A., Duarte, S., Zarrinpar, A., Malany, S., & Peddibhotla, S.
(2025). Targeting CXCR6 Disrupts β-Catenin Signaling and Enhances Sorafenib Response in Hepatocellular Carcinoma. Cancers, 17(23), 3818.
https://doi.org/10.3390/cancers17233818